Trade receivables increased 52.3%
Trade receivables changed +52.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables changed +52.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed +14.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +51.3% from the comparable as-filed period.
Operating cash flow changed +45.9% from the comparable as-filed period.
Gross margin changed +267 basis points from the comparable as-filed period.
Cash & equivalents changed -39.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital / assets changed -1072 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital changed -47.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Capital expenditure changed +27.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +12.3% from the comparable as-filed period.
Revenue changed +12.0% from the comparable as-filed period.
Inventory / revenue changed -231 basis points from the comparable as-filed period.
Receivables / revenue changed +1733 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +267 basis points from the comparable as-filed period.
Stock-based compensation changed +62.5% from the comparable as-filed period.
Operating cash-flow margin changed +601 basis points from the comparable as-filed period.
Free-cash-flow margin changed +540 basis points from the comparable as-filed period.
Total assets changed +16.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed +16.0% from the comparable as-filed period.
Operating margin changed +5 basis points from the comparable as-filed period.
Current assets changed -12.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current ratio changed -23.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Capex / revenue changed +61 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +12.6% from the comparable as-filed period.
Shares outstanding changed -3.0% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
Cost of revenue changed +0.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed -1.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed +9 basis points from the comparable as-filed period.
Operating margin changed -310 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed +15.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed -24.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed -53.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital / assets changed -1259 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital changed -57.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed -16.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -340 basis points from the comparable as-filed period.
Shares outstanding changed -3.8% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Current ratio changed -25.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Capex / revenue changed +215 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed -175.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Receivables / revenue changed +829 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -1271 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed -101.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash-flow margin changed -1056 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed +71.1% from the comparable as-filed period.
Revenue changed +1.0% from the comparable as-filed period.
Gross margin changed +10 basis points from the comparable as-filed period.
Inventory changed -16.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Total assets changed +8.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +4.9% from the comparable as-filed period.
Current liabilities changed +0.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed -7 basis points from the comparable as-filed period.
Cost of revenue changed +0.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed +60 basis points from the comparable as-filed period.
Gross profit changed +1.2% from the comparable as-filed period.
Stock-based compensation changed -0.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.